PeptideNerds

The Weight Loss Stack

Combines the appetite-suppressing power of semaglutide with tesamorelin's targeted visceral fat reduction. Semaglutide reduces caloric intake through GLP-1 receptor activation while tesamorelin specifically targets the deep abdominal fat linked to metabolic disease.

Difficulty

intermediate

Est. Cost

$400-1,200

Duration

6-12 months

Peptides

2 compounds

Protocol

Peptide Dose Frequency Timing Role
Semaglutide 0.25-2.4mg Once weekly Same day each week, any time GLP-1 receptor agonist for appetite suppression and metabolic improvement
Tesamorelin 2mg Once daily Morning, empty stomach GHRH analog targeting visceral adipose tissue reduction

Notes

Semaglutide handles the appetite and caloric intake side. Tesamorelin is FDA-approved (as Egrifta) for reducing visceral fat in HIV-associated lipodystrophy and has strong data for visceral fat reduction in broader populations. Start semaglutide at 0.25mg and titrate every 4 weeks. Tesamorelin should be taken on an empty stomach (no food 2 hours before, 30 min after). High protein intake (1g per pound bodyweight) and resistance training 3-4x/week are essential to preserve lean mass during rapid weight loss.

Related goals

Related stacks

Free Peptide Weight Loss Guide

Semaglutide vs. tirzepatide vs. retatrutide. Dosing protocols, side effects, gray market sourcing, and what the clinical trials found.

Alejandro Reyes

Written by Alejandro Reyes

Founder & Lead Researcher

PN

Reviewed by Peptide Nerds Editorial · Updated March 2026

Medical Disclaimer: Peptide stacks are not FDA-approved protocols. This information is for educational purposes only. Consult a qualified healthcare provider before combining any peptides.